Epidemiology, Correlation and Predictive Value of Disease Activity and Biomarkers in RA [rheumatoid arthritis] Patients Initiated on Infliximab in Clinical Practice

Trial Profile

Epidemiology, Correlation and Predictive Value of Disease Activity and Biomarkers in RA [rheumatoid arthritis] Patients Initiated on Infliximab in Clinical Practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Infliximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms REMARK
  • Sponsors Schering-Plough
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jun 2010 Patient numbers amended from (694) to (728) as reported by ClinicalTrials.go
    • 29 Sep 2008 Actual patient number (694) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top